iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Bajaj Healthcare forays into the highly-regulated Opiate processing biz

16 Jul 2022 , 01:33 AM

Bajaj Healthcare announced that it has received two letters of Award on 12 July 2022 for the manufacture of AlkaloidsAPIs from Government of India Department of Revenue Office of Chief Controller Govt Opium Alkaloid Factories as follows 1 Letter of Award to manufacture Alkaloids APIs from processing of 500 MT of unlanced poppy capsule along with Straw on an annual basis 2 Letter of Award to manufacture Alkaloids APIs from processing of 100 MT of Opium Gum on an annual basis The company plans to execute both these tenders at their API manufacturing unit located at Savli Gujarat India

Related Tags

  • Announcements
  • BSE
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.